Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
Authors (first, second and last of 8)
This is part of 1 collection:
Volume 5, issue 2, April 2013
11 articles in this issue
-
-
Neuroprotective effects of D-Ala2GIP on Alzheimer's disease biomarkers in an APP/PS1 mouse model
Authors
-
Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models
Authors (first, second and last of 11)
-
-
-
Modeling the heterogeneity in risk of progression to Alzheimer's disease acrosscognitive profiles in mild cognitive impairment
Authors (first, second and last of 9)
-
-
-
Biomarkers for Alzheimer's disease in plasma, serum and blood - conceptual and practical problems
Authors
This is part of 1 collection: -
Plasma tau levels in Alzheimer's disease
Authors (first, second and last of 7)
This is part of 1 collection:
-
Plasma amyloid beta measurements - a desired but elusive Alzheimer's disease biomarker
Authors
This is part of 1 collection:
